the following articles have been added to the PubMed archives on the wwweb in the past 30 days: PD: clinical signs and symptoms, neural mechanisms, PET, and therapeutic interventions. PMID: 11530892 Updated guidelines for the management of PD. PMID: 11530583 Subthalamic GAD gene transfer in PD patients who are candidates for DBS. PMID: 11529246 Mutant beta-spectrin 4 causes auditory and motor neuropathies in quivering mice. PMID: 11528393 Automatic orienting of visuospatial attention in PD. PMID: 11527561 Pattern of intrusions in verbal recall: comparison of AD, PD, and frontal lobe dementia. PMID: 11527341 Productive syntax abilities in Huntington's and PDs. PMID: 11527333 Microglia in neurodegeneration: molecular aspects. PMID: 11526957 Effects of bilateral subthalamic stimulation on cognitive function in PD. PMID: 11493162 Subthalamic DBS: neurobehavioral concerns. PMID: 11493159 DBS in the treatment of PD: A cost-effectiveness analysis. PMID: 11524476 Fetal cell implantation to treat PD: questions for the future. PMID: 11523667 Cell transplantation in PD: implications for human clinical trials. PMID: 11523666 Is transplantation to treat PD dead? PMID: 11523665 Pathogenesis of idiopathic PD. PMID: 11523160 Group I mGluR antagonist AIDA protects nigral DA cells from MPTP-induced injury. PMID: 11522935 The subthalamic nucleus in PD: somatotopic organization and physiological characteristics. PMID: 11522580 Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells. PMID: 11520910 Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline. PMID: 11520893 Does PD Have an Immunological Basis?: The Evidence and its Therapeutic Implications. PMID: 11520246 Antagonists reduce levodopa-induced dyskinesia in the mptp-lesioned primate model of PD. PMID: 11520128 l-Dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-o-methyltransferase. PMID: 11520127 A source of cells for transplantation in PD. PMID: 11520124 Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. PMID: 11519733 Deficiency and excess of iron in brain function and dysfunction. PMID: 11519673 Abstracts from the 2nd Congress Deutsche Parkinson March 7-10, 2001. PMID: 11519488 Function of monoamine neurotransmitter transporters. PMID: 11519142 Successful treatment of excessive daytime sleepiness in PD with modafinil. PMID: 11518012 Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in PD. PMID: 11518003 Botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism. PMID: 11517998 Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive MPTP macaque model of PD. PMID: 11517273 Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. PMID: 11516769 Basal ganglia dysfunction, working memory, and sentence comprehension in patients with PD. PMID: 11516448 (-)-1-(Benzofuran-2-yl)-2-propylaminopentane enhances locomotor activity in rats due to its ability to induce dopamine release. PMID: 11516435 Subthalamic nucleus lesions reduce low frequency oscillatory firing of substantia nigra pars reticulata neurons in a rat model of PD. PMID: 11516415 Does a vegan diet reduce risk for PD? PMID: 11516224 Dopamine transporter immunoreactivity in peripheral blood lymphocytes in PD. PMID: 11515746 Cultured human foetal cerebral cortex, transfected with tyrosine hydroxylase cDNA, as a source of neural transplant material. PMID: 11515744 New aspects of physiological and pathophysiological functions of adenosine A2A receptor in basal ganglia. PMID: 11515525 Evidence for target-specific outgrowth from subpopulations of grafted human dopamine neurons. PMID: 11514985 Comparison of extrapyramidal signs in dementia with lewy bodies and PD. PMID: 11514644 Electromyographic differentiation of tremors. PMID: 11514245 Regularity of force tremor in PD. PMID: 11514241 XANES spectroscopy of a single neuron from a patient with PD. PMID: 11513007 Magnetisation transfer measurements of the subcortical grey and white matter in PD with and without dementia and in PSP. PMID: 11512582 Fatigue among elders in caregiving and noncaregiving roles. PMID: 11512167 Parkinsonism and occupational exposure to pesticides. PMID: 11511745 Outcome of unilateral pallidotomy in advanced PD: cohort study of 32 patients. PMID: 11511714 Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to PD or MSA with observations on orthostatic hypotension. PMID: 11511713 Preclinical syndromes predict dementia: the Sydney older persons study. PMID: 11511700 Transgenic invertebrate models of age-associated neurodegenerative diseases. PMID: 11511401 Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in PD? PMID: 11511392 Rat marrow stromal cells rapidly transduced with a self-inactivating retrovirus synthesize L-DOPA in vitro. PMID: 11509954 Determining minimally important differences for the PDQ-39 PD questionnaire. PMID: 11509307 Neuroendocrinology of ageing. PMID: 11509304 Twelve-month safety of entacapone in patients with PD. PMID: 11509081 Spinal movement and performance of a standing reach task in participants with and without PD. PMID: 11509070 Levodopa induces dyskinesias in normal squirrel monkeys. PMID: 11506410 Blinded PET study of dopamine cell implantation for PD. PMID: 11506400 Metabolic enzyme expression in dopaminergic neurons in PD: an in situ hybridization study. PMID: 11506395 PD. Update in diagnosis and symptom management. PMID: 11505857 Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of PD. PMID: 11504916 Dynorphins Protect Rat Mesencephalic Dopaminergic Neurons against Inflammatory Damage. PMID: 11504811 Differential sensitivity of mesencephalic neurons to inhibition of phosphatase 2a. PMID: 11504786 Deep brain stimulator electrodes used for lesioning: proof of principle. PMID: 11504112 Electrical stimulation of the prelemniscal radiation in the treatment of PD: an old target revised with new techniques. PMID: 11504105 Entacapone: new preparation. Comparative data are lacking. PMID: 11503812 Frequency of bowel movements and the future risk of PD. PMID: 11502913 Differential cell death induced by salsolinol with and without copper. PMID: 11502874 Metoprolol-induced changes in myocardial (123)i-metaiodobenzylguanidine uptake in PD. PMID: 11502719 Green tea extract may have neuroprotective effects in PD. PMID: 11502329 Membrane Binding and Self-Association of alpha-Synucleins. PMID: 11502187 Does balance control deficit account for walking difficulty in PD? PMID: 11501233 Motor sequencing deficits in schizophrenia: a comparison with PD. PMID: 11499989 Paroxysmal hypertensive crises induced by selegiline in a patient with PD. PMID: 11499649 L-Dopa induces dyskinesia in normal monkeys: behavioural and pharmacokinetic observations. PMID: 11498717 Expectation and dopamine release: mechanism of the placebo effect in PD. PMID: 11498597 Intermuscular coherence in PD: relationship to bradykinesia. PMID: 11496152 Auditory rhythmicity enhances movement and speech motor control in patients with PD. PMID: 11495422 In vitro generation and transplantation of precursor-derived human dopamine neurons. PMID: 11494363 Cardiovascular effects of domperidone in patients with PD treated with apomorphine. PMID: 11493225 Vascular parkinsonism: a distinct, heterogeneous clinical entity. PMID: 11493219 Distribution and modulation of histamine h(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with PD. PMID: 11493035 Dementia with Lewy bodies. PMID: 11490548 Prevalence of PD in bulgaria. PMID: 11490169 Predicting fallers in a community-based sample of people with PD. PMID: 11490147 Single administration of GDNF into the striatum induced protection and repair of the nigrostriatal dopaminergic system in a model of hemiparkinsonism. PMID: 11490075 Future of neuroprotection in PD. PMID: 11489679 The use of estrogen in the treatment of PD. PMID: 11489678 Approaching disturbed sleep in late PD: first step toward a proposal for a revised UPDRS. PMID: 11489677 Dystonia and parkinsonism. PMID: 11489676 Motor fluctuations and dyskinesia in PD. PMID: 11489675 Levodopa prolongs life expectancy and is non-toxic to substantia nigra. PMID: 11489674 Functional brain networks in PD. PMID: 11489673 Molecular neurotoxicological models of Parkinsonism: focus on genetic manipulation of mice. PMID: 11489672 Dopamine receptors: understanding the pathophysiology of fluctuations in PD. PMID: 11489671 5th International Symposium on the Treatment of PD. PMID: 11489670 Reward signaling by dopamine neurons. PMID: 11488395 One step back and one, possibly two, steps forward. The different approaches to PD. PMID: 11488194 Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions. PMID: 11487667 Restorative plasticity of dopamine neuronal transplants depends on the degree of hemispheric dominance. PMID: 11487648 Subcutaneous continuous apomorphine infusion in fluctuating patients with PD. PMID: 11487217 Reduced L-dopa absorption and increased clinical fluctuations in Helicobacter pylori-infected PD patients. PMID: 11487216 Which target for DBS in PD? Subthalamic nucleus versus globus pallidus internus. PMID: 11487215 Non-motor effects of DBS of the subthalamic nucleus in PD: preliminary physiological results. PMID: 11487214 Cytogenetic analysis oxidative damage in lymphocytes of PD patients. PMID: 11487213 Stimulation of growth hormone release in MSA, PD and idiopathic cerebellar ataxia. PMID: 11487211 Amantadine for dyskinesia in patients affected by severe PD. PMID: 11487209 The parkin gene is not a major susceptibility locus for typical late-onset PD. PMID: 11487208 Interaction between dopamine and adenosine A2A receptors as a basis for the treatment of PD. PMID: 11487207 Proton magnetic resonance spectroscopy (1H-MRS) in de novo PD patients. PMID: 11487206 DBS of the subthalamic nucleus: selection of patients and clinical results. PMID: 11487205 Decreased platelet glutamate uptake and genetic risk factors in patients with PD. PMID: 11487204 Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of PD. PMID: 11487201 Chronic bilateral electrical stimulation of the subthalamic nucleus for advanced PD. PMID: 11487200 Hallucinatory psychosis in early-onset PD: drug-induced complication or psychiatric illness? PMID: 11487198 The parkin gene and its phenotype. PMID: 11487197 The status of dopamine nerve terminals in PD and essential tremor. PMID: 11487195 Perfusion ECD/SPECT in the characterization of cognitive deficits in PD. PMID: 11487194 The role of language areas in motor control dysfunction in PD. PMID: 11487193 Efficacy and tolerability of dopamine agonists in a parkinsonian population. PMID: 11487183 A PET study: the effect of amantadine on the dopaminergic system. PMID: 11487182 Unawareness of dyskinesias in Parkinson's and Huntington's diseases. PMID: 11487181 Cell survival and clinical outcome following intrastriatal transplantation in PD. PMID: 11487048 janet paterson: an akinetic rigid subtype, albeit perky, parky . pd: 54/41/37 cd: 54/44/43 tel: 613 256 8340 email: [log in to unmask] . smail: 375 Country Street, Apt 301, Almonte, Ontario, Canada, K0A 1A0 . a new voice: the nnnewsletter: http://groups.yahoo.com/group/janet313/ . a new voice: the wwweb site: http://www.geocities.com/janet313/ . ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn